BeiGene nears finish on landmark Star IPO

BeiGene is on the verge of wrapping up the largest ever biotechnology IPO on Shanghai’s Nasdaq-style Star board, with institutional and retail investors both vying for shares on Thursday. BeiGene is ... ( read original story ...)